Advanced Medical Solutions Group plc Share Price

Equities

AMS

GB0004536594

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 16:35:17 24/04/2024 BST 5-day change 1st Jan Change
192.2 GBX +0.95% Intraday chart for Advanced Medical Solutions Group plc +5.60% -7.37%

Financials

Sales 2023 126M 157M 12.62B Sales 2024 * 178M 222M 17.83B Capitalization 418M 520M 41.77B
Net income 2023 15M 18.69M 1.5B Net income 2024 * 9M 11.21M 900M EV / Sales 2023 3.1 x
Net cash position 2023 60.16M 74.94M 6.02B Net Debt 2024 * 12.31M 15.33M 1.23B EV / Sales 2024 * 2.41 x
P/E ratio 2023
28.6 x
P/E ratio 2024 *
42.3 x
Employees 800
Yield 2023
1.14%
Yield 2024 *
1.37%
Free-Float 97.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.95%
1 week+5.60%
Current month-1.94%
1 month+3.00%
3 months-7.82%
6 months+3.00%
Current year-7.37%
More quotes
1 week
180.20
Extreme 180.2
192.66
1 month
176.60
Extreme 176.6
199.20
Current year
176.60
Extreme 176.6
220.00
1 year
165.60
Extreme 165.6
261.00
3 years
165.60
Extreme 165.6
347.00
5 years
165.60
Extreme 165.6
357.21
10 years
106.85
Extreme 106.8545
374.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 30/06/05
Director of Finance/CFO 52 04/10/11
Chief Tech/Sci/R&D Officer - 31/12/01
Members of the board TitleAgeSince
Director/Board Member 66 31/01/21
Chief Executive Officer 57 30/06/05
Director/Board Member 58 01/08/21
More insiders
Date Price Change Volume
24/04/24 192.2 +0.95% 4,685,146
23/04/24 190.4 +1.49% 284,402
22/04/24 187.6 +2.18% 427,467
19/04/24 183.6 -0.43% 218,849
18/04/24 184.4 +0.22% 344,397

Delayed Quote London S.E., April 24, 2024 at 04:35 pm

More quotes
Advanced Medical Solutions Group plc is a United Kingdom-based company that specializes in the design, development, manufacture and distribution of novel tissue-healing technologies, including advanced wound care products, surgical dressings and medical grade materials, as well as medical adhesives and sutures for closing and sealing tissue. The Company manufactures a range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats. It operates through two divisions for its sales, marketing and research and development (R&D) activities, including Surgical and Woundcare. Its surgical business unit is focused on selling and marketing its branded products and are sold directly and through distributors. Its Woundcare business unit is focused on distribution and marketing its products that are supplied to medical device partners under their own brands. The Company offers its products under ActivHeal, LiquiBand and RESORBA.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
1.922 GBP
Average target price
2.522 GBP
Spread / Average Target
+31.23%
Consensus